These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 26787896)

  • 1. Aminoacyl β-naphthylamides as substrates and modulators of AcrB multidrug efflux pump.
    Kinana AD; Vargiu AV; May T; Nikaido H
    Proc Natl Acad Sci U S A; 2016 Feb; 113(5):1405-10. PubMed ID: 26787896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic analysis of the inhibition of the drug efflux protein AcrB using surface plasmon resonance.
    Mowla R; Wang Y; Ma S; Venter H
    Biochim Biophys Acta Biomembr; 2018 Apr; 1860(4):878-886. PubMed ID: 28890187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis for inhibition of AcrB multidrug efflux pump by novel and powerful pyranopyridine derivatives.
    Sjuts H; Vargiu AV; Kwasny SM; Nguyen ST; Kim HS; Ding X; Ornik AR; Ruggerone P; Bowlin TL; Nikaido H; Pos KM; Opperman TJ
    Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3509-14. PubMed ID: 26976576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Boosting the Antibacterial Activity of Azithromycin on Multidrug-Resistant
    Al-Marzooq F; Ghazawi A; Daoud L; Tariq S
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanism of MBX2319 inhibition of Escherichia coli AcrB multidrug efflux pump and comparison with other inhibitors.
    Vargiu AV; Ruggerone P; Opperman TJ; Nguyen ST; Nikaido H
    Antimicrob Agents Chemother; 2014 Oct; 58(10):6224-34. PubMed ID: 25114133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlorpromazine and Amitriptyline Are Substrates and Inhibitors of the AcrB Multidrug Efflux Pump.
    Grimsey EM; Fais C; Marshall RL; Ricci V; Ciusa ML; Stone JW; Ivens A; Malloci G; Ruggerone P; Vargiu AV; Piddock LJV
    mBio; 2020 Jun; 11(3):. PubMed ID: 32487753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Random mutagenesis of the multidrug transporter AcrB from Escherichia coli for identification of putative target residues of efflux pump inhibitors.
    Schuster S; Kohler S; Buck A; Dambacher C; König A; Bohnert JA; Kern WV
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6870-8. PubMed ID: 25182653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of site-directed mutations in multidrug efflux pump AcrB examined by quantitative efflux assays.
    Kinana AD; Vargiu AV; Nikaido H
    Biochem Biophys Res Commun; 2016 Nov; 480(4):552-557. PubMed ID: 27789287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of the Drug Binding Pocket Defects of the AcrB Multidrug Efflux Pump Protein of Escherichia coli.
    Soparkar K; Kinana AD; Weeks JW; Morrison KD; Nikaido H; Misra R
    J Bacteriol; 2015 Oct; 197(20):3255-64. PubMed ID: 26240069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proof of an Outer Membrane Target of the Efflux Inhibitor Phe-Arg-β-Naphthylamide from Random Mutagenesis.
    Schuster S; Bohnert JA; Vavra M; Rossen JW; Kern WV
    Molecules; 2019 Jan; 24(3):. PubMed ID: 30699887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some ligands enhance the efflux of other ligands by the Escherichia coli multidrug pump AcrB.
    Kinana AD; Vargiu AV; Nikaido H
    Biochemistry; 2013 Nov; 52(46):8342-51. PubMed ID: 24205856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis for the different interactions of congeneric substrates with the polyspecific transporter AcrB.
    Malvacio I; Buonfiglio R; D'Atanasio N; Serra G; Bosin A; Di Giorgio FP; Ruggerone P; Ombrato R; Vargiu AV
    Biochim Biophys Acta Biomembr; 2019 Jul; 1861(7):1397-1408. PubMed ID: 31075229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug binding properties of the AcrB efflux pump characterized by molecular dynamics simulations.
    Vargiu AV; Nikaido H
    Proc Natl Acad Sci U S A; 2012 Dec; 109(50):20637-42. PubMed ID: 23175790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a series of 2-napthamide derivatives as inhibitors of the drug efflux pump AcrB for the reversal of antimicrobial resistance.
    Wang Y; Mowla R; Guo L; Ogunniyi AD; Rahman T; De Barros Lopes MA; Ma S; Venter H
    Bioorg Med Chem Lett; 2017 Feb; 27(4):733-739. PubMed ID: 28129976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered spectrum of multidrug resistance associated with a single point mutation in the Escherichia coli RND-type MDR efflux pump YhiV (MdtF).
    Bohnert JA; Schuster S; Fähnrich E; Trittler R; Kern WV
    J Antimicrob Chemother; 2007 Jun; 59(6):1216-22. PubMed ID: 17062614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of RND multidrug efflux pumps.
    Nikaido H; Takatsuka Y
    Biochim Biophys Acta; 2009 May; 1794(5):769-81. PubMed ID: 19026770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efflux inhibitor phenylalanine-arginine beta-naphthylamide (PAβN) permeabilizes the outer membrane of gram-negative bacteria.
    Lamers RP; Cavallari JF; Burrows LL
    PLoS One; 2013; 8(3):e60666. PubMed ID: 23544160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of Real-Time Assays To Distinguish Multidrug Efflux Pump-Inhibiting and Outer Membrane-Destabilizing Activities in Escherichia coli.
    Misra R; Morrison KD; Cho HJ; Khuu T
    J Bacteriol; 2015 Aug; 197(15):2479-88. PubMed ID: 25962916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance in Escherichia coli: variable contribution of efflux pumps with respect to different fluoroquinolones.
    Huguet A; Pensec J; Soumet C
    J Appl Microbiol; 2013 May; 114(5):1294-9. PubMed ID: 23414263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug transport mechanism of the AcrB efflux pump.
    Pos KM
    Biochim Biophys Acta; 2009 May; 1794(5):782-93. PubMed ID: 19166984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.